Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Current Assets: 2010-2025

Historic Current Assets for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $295.1 million.

  • Cross Country Healthcare's Current Assets fell 1232.17% to $295.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 1448.52%. This contributed to the annual value of $335.0 million for FY2024, which is 1964.02% down from last year.
  • Per Cross Country Healthcare's latest filing, its Current Assets stood at $295.1 million for Q3 2025, which was down 1232.17% from $309.1 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Current Assets ranged from a high of $718.3 million in Q2 2022 and a low of $269.7 million during Q1 2021
  • Its 5-year average for Current Assets is $445.6 million, with a median of $387.3 million in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 17757.64% in 2021, then tumbled by 4028.51% in 2024.
  • Cross Country Healthcare's Current Assets (Quarter) stood at $508.3 million in 2021, then soared by 33.27% to $677.4 million in 2022, then tumbled by 38.46% to $416.9 million in 2023, then decreased by 19.64% to $335.0 million in 2024, then decreased by 11.91% to $295.1 million in 2025.
  • Its Current Assets stands at $295.1 million for Q3 2025, versus $309.1 million for Q2 2025 and $325.2 million for Q1 2025.